Evan Rachlin
Listed on 3 Form D filings across 2+ issuers
· Director, Executive Officer
Associated issuers
- Iambic Therapeutics, Inc. CIK 1997038 · CA
- Ascenta Capital Fund I, L.P. CIK 1957458 · DE
Filings (3)
-
Iambic Therapeutics, Inc.D · Apr 8, 2026 · CA · Biotechnology$50MView filing →
-
Iambic Therapeutics, Inc.D · Nov 21, 2025 · CA · Biotechnology$125MView filing →
-
Ascenta Capital Fund I, L.P.D · Feb 7, 2025 · DE · Pooled Investment Fund$350MView filing →